Notice of Intent to Sole Source INTERCEPT Blood System for Platelets
Closed Pre-Solicitation Posted
- Solicitation number
- 12160537
- Agency
-
Defense Health Agency
Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 621511 Medical Laboratories
- Place of performance
- Portsmouth, Virginia 23708, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Health Agency intends to award a sole source, firm-fixed-price contract to CERUS Corporation for the commercial-off-the-shelf INTERCEPT Blood System for Platelets. This purchase will be made utilizing Simplified Acquisition Procedures, with a base year of performance from January 1, 2025 to December 31, 2025, and two option years. The total estimated value of the contract is $210,816.00. Responses to this notice of intent must demonstrate clear and convincing evidence that competition would be advantageous to the Government, would not be cost or time prohibitive, and would not hinder the mission objective of Naval Medical Center Portsmouth.
This procurement is not set-aside. CERUS Corporation is the only source available to provide the INTERCEPT Blood System for Platelets. The Government will not be responsible for any costs incurred by responding to this notice, and this is not a request for quote or proposals.
Notice text
The Government hereby submits a notice of intent to award a sole source Firm-Fixed-Price contract to CERUS Corporation for commercial-off-the-shelf (COTS) INTERCEPT Blood System for Platelets. This purchase will be made utilizing Simplified Acquisition Procedures in accordance with Federal Regulation (FAR) Part 13.106-1(b) for purchases not exceeding the simplified acquisition threshold of $250,000. The contract will consist of a base year and 2 option years; the period of performance for the base year is 01Jan2025 – 31Dec2025. CERUS Corporation is the only source available to provide INTERCEPT Blood System for Platelets. The total estimated value is $210,816.00. Responses to this notice must demonstrate clear and convincing evidence that competition would be advantageous to the Government, would not be cost or time prohibitive, and would not hinder the mission objective of Naval Medical Center Portsmouth. The determination not to compete this proposed contract action is solely within the discretion of the Government. Information received will normally be considered for the purposes of determining whether to conduct a competitive procurement. The Government will not be responsible for any costs incurred by responding to this notice. This is not a request for quote or proposals. Questions or comments to this Notice of Intent should be directed to Contract Specialists, Cynthia.e.scharnowske.civ@health.mil. Please indicate in the subject of your email: Notice of Intent Submission 12160537.
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Notice of Intent to Sole Source ONKOS Surgical MY3D Distal Radial Osteotomy Kit for Naval Medical Center Portsmouth | Defense Health Agency | No set-aside | |
| Notice of Award Maintenance for Government owned BacT/ALERT 3D Equipment. | Medical Command | No set-aside | |
| 6505--Human Blood and Blood Products | Veterans Integrated Service Network 17 | No set-aside | |
| J066--Azenta NitroStore System PM and Support Services | Veterans Integrated Service Network 4 | No set-aside | |
| Notice of Intent to Sole Source – Boston Scientific | NIH Clinical Center | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity